Mariateresa Fulciniti

12PUBLICATIONS
87CO-AUTHORS
Molecular targetsAutoimmunityMicroelectromechanical systems (MEMS)Predictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 15, 2026
The role of RAD23A in DNA repair and proteasome-dependent protein degradation in multiple myeloma.

|Dec 11, 2025
Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple Myeloma.

Anil Aktas Samur, Jill Corre, Srikanth Talluri

|Nov 17, 2025
Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma.

W Frank Lenoir, Michael R McKeown, Giulia Giorgetti

|Oct 17, 2025
ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3.

Mariateresa Fulciniti, Yao Yao, Tommaso Perini

|May 02, 2025
CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma.

Giulia Giorgetti, Elena Maroto-Martin, Debora Soncini

|Mar 07, 2025
Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple Myeloma.

Eugenio Morelli, Caroline Fidalgo Ribeiro, Silvia D Rodrigues

Pageof 2

Frequent Collaborators

10 joint publications

Nikhil Munshi

7 joint publications

Kenneth C Anderson

6 joint publications

Mehmet Samur

5 joint publications

Anil Aktas-Samur